Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

Common/shared responsibilities between jobs.
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
The Statisticians Role in Pharmaceutical Development
Nursing Research Opportunities in the USPHS CAPT. Victoria L. Anderson, RN, CRNP, MSN.
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development Critical Path.
What Do Toxicologists Do?
Special Topics in IND Regulation
Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
Stefan Franzén Introduction to clinical trials.
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
U of Arizona Innovation Conference 20 September 2011 Marlene E. Haffner, MD, MPH Haffner Associates, LLC.
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
1 Alvimopan RiskMAP Joyce Weaver, Pharm.D., BCPS Office of Surveillance and Epidemiology.
Food and Drug Administration Center for Biologics Evaluation and Research The Office of Cellular, Tissue and Gene Therapies Web Seminar Series presents:
INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL Sheree Miller, Pharm.D. University of Washington Medical Center
Stages of drug development
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Overview of the Clinical Trial & Protocol Jane Fendl March 31, 2010
Figure 4.1 NEW PRODUCT DEVELOPMENT PROCESS Finance Corporate strategy and portfolio decisions Regulatory affairs Marketing and sales + market research.
Yesterday, today, and tomorrow
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Feldman 20 February Clinical Trials Design Martha A. Feldman, RAC Drug & Device Development Co., Inc. P.O. Box 3515 Redmond, WA USA
1 Value Assessment of Development-Stage Assets Pharmaceutical Products, Medical Devices, and Related Intellectual Property Frank S. Castellana, M.D., Eng.Sc.D.
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
Stefan Franzén Introduction to clinical trials.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
INTRODUCTION TO RA.
Investigational New Drug Application (IND)
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
From the Lab to Market Unit 3.04 Understanding Biotechnology research & Development.
Exploratory IND Studies
Clinical Pharmacy Part 2
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
1 Statistics in Drug Development Mark Rothmann, Ph. D.* Division of Biometrics I Food and Drug Administration * The views expressed here are those of the.
1/33.  What is INDA ?  Types of INDAs  Objectives of INDAs  Format & Contents of an INDA  IND Safety reports  IND Annual Reports  IND Review Process.
Molecule-to-Market-Place Quality
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
Privacy Symposium / HIPAA Summit
“Journey of a Drug” From Test Tube TO Prescribing Physician.
UNIT-II CLINICAL DATA. UNIT-II CLINICAL DATA: Clinical Data, Application, Challenges, Solutions, Clinical Data Management System.
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
1 PRIORITY MEDICINES FOR EUROPE AND THE WORLD Barriers to Pharmaceutical Innovation Richard Laing EDM/PAR WHO.
Clinical Trials - PHASE II. Introduction  Important part of drug discovery process  Why important??  Therapeutic exploratory trial  First time in.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Making Clinical Trials More Efficient Site Management Organization (SMO)
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
GCP (GOOD CLINICAL PRACTISE)
Clinical Trials.
PRAGMATIC Study Designs: Elderly Cancer Trials
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
FDA DRUG APPROVAL FDA’s Lengthy Drug Approval Process in Twelve Steps Overview of the FDA Drug Approval Process Drug Developed June 13, 2016 | Emilia Varrone.
Study Development and Design Suzanne Adams RN MPH Director, Clinical Operations Jefferson Clinical Research Institute.
Drug Development Process Stages involved in Regulating Drugs
Drug Discovery &Development
Regulatory– Terms & Definitions רגולציה - מונחים והגדרות
Clinical Trials — A Closer Look
The Many Careers of Pharmacy
Prof. Dr. Basavaraj K. Nanjwade
How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.
Introduction to Clinical Pharmacy
Beyond Academia.
Drug Design and Drug Discovery
Considerations for Successful Biopharmaceutical Product Development: Discovery to Proof of Concept -A Panel Discussion Stanley C. McDermott, PharmD, MS,
Presentation transcript:

Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development

Outline Describe the functions and responsibilities performed by various departments within pharmaceutical industry R&D. Highlight career opportunities within these departments for which individuals with a PharmD degree are well-suited.

Goal of Pharmaceutical R&D The underlying goal of pharmaceutical R&D is to create new knowledge, upon which a commercial product (and company) can be financially successful. Specific R&D goals vary for different pharmaceutical companies based on focus, size, history, risk tolerance, available resources, and expertise.

Major R&D Departments (bringing “molecules to market”) Chemistry PK Regulatory Literature Services Licensing Discovery Pharmacology Toxicology Clinical Development Pharmaceutics Project Management Pharmacy Market Planning

Steps From Concept to Marketed Product Identify the medical need.

Steps From Concept to Marketed Product Identify the medical need. Define the molecular target.

Steps From Concept to Marketed Product Identify the medical need. Define the molecular target. Design a series of new compounds that hit the target.

Steps From Concept to Marketed Product Identify the medical need. Define the molecular target. Design a series of new compounds that hit the target. Screen these compounds preclinically for optimum effects and potential safety and pharmacokinetic considerations. Select the best candidate based on desirable properties and conduct more definitive tests.

Steps From Concept to Marketed Product Identify the medical need. Define the molecular target. Design a series of new compounds that hit the target. Screen these compounds preclinically for optimum effects and potential safety and pharmacokinetic considerations. Select the best candidate based on desirable properties and conduct definitive tests. Formulate the compound.

Steps From Concept to Marketed Product Study the compound clinically through a series of clinical trials that establish the safety and efficacy for the intended population.

Pr /-14 Study Design Baseline Evaluation S T R A T I F I C A T I O N + R A N D O M I Z A T I O N Regimen A*: Gemcitabine+ HDAC-I Regimen B*: Gemcitabine+ Placebo Follow-Up for 12 months after last patient enrolled *Administered as a 28-day course as long as medically appropriate Regimen A: Gemcitabine 1000 mg/m 2 IV on days 1, 8 and 15 of a 28-day cycle HDAC-I 6 mg/m 2 PO days 1-21 of a 28-day cycle Regimen B: Gemcitabine 1000 mg/m 2 IV on days 1, 8 and 15 of a 28-day cycle Placebo 6 mg/m 2 PO days 1-21 of a 28-day cycle Study Design

Steps From Concept to Marketed Product Study the compound clinically through a series of clinical trials that establish the safety and efficacy for the intended population. Satisfy Regulatory agencies that the compound is safe and effective for the intended purpose.

Steps From Concept to Marketed Product Study the compound clinically through a series of clinical trials that establish the safety and efficacy for the intended population. Satisfy Regulatory agencies that the compound is safe and effective for the intended purpose. Launch, promote, and sell the product.

Steps From Concept to Marketed Product Study the compound clinically through a series of clinical trials that establish the safety and efficacy for the intended population. Satisfy Regulatory agencies that the compound is safe and effective for the intended purpose. Launch, promote, and sell the product. Support the commercial success of the product with post-marketing studies.

Major R&D Departments (bringing “molecules to market”) Chemistry PK Regulatory Literature Services Licensing Discovery Pharmacology Toxicology Clinical Development Pharmaceutics Project Management Pharmacy Market Planning

Pharmacy Services in R&D Support R&D through participation on all project teams. Manage supplies and flow of NCE between Chemical Development, Pharmaceutics/ Formulation, and users (preclinical and clinical studies). Package, label, distribute, and maintain accountability for clinical trial materials. Common entry point for PharmDs with no industry experience.

Clinical Development Department Responsible for creating the optimal strategy to assess the clinical utility of the new compound. Responsible for planning and conducting a series of clinical protocols designed to assess the efficacy and safety of the new compound, with the goal of getting the compound registered.

Major Components of the Clinical Development Department Statistician Outcomes Research Clinician Data Services Medical Writer Clinical Research Associate

Conducting a Protocol (101) Clinician writes the protocol to accomplish specific scientific objectives. Clinician recruits Investigators (MDs) to conduct the study by treating their eligible patients according to the protocol and recording the study data. CRAs monitor the completeness and accuracy of the investigator’s data and bring the data in-house.

Conducting a Protocol (101) Data handling specialists enter the data and program the output. Statisticians analyze the data. Clinician interprets the data. Medical Writer summarizes the data. Clinician utilizes the new knowledge in the design of the next protocol.

Phases of Clinical Development Phase 1 protocols: –Objectives are to establish dose ranges, pharmacokinetics and safety/tolerance. –Conducted in normal volunteers or in patients with targeted indication

Phases of Clinical Development Phase 2 protocols: –Objectives are to assess the activity of the compound in patients with the target disease and to assess safety/tolerance.

Phases of Clinical Development Phase 3 protocols: –Objectives are to assess the efficacy and safety of the compound in patients with the target disease, relative to standard therapy.

Phases of Clinical Development Phase 4 (post-marketing) protocols: –Objectives are to further characterize the effects in subpopulations or with an emphasis on additional endpoints.

Job Description for Clinical Scientist “Responsible for developing new protocols, implementing, conducting, interpreting, and summarizing clinical studies. Presentation of plans and data internally and externally as appropriate.”

Job Description for Clinical Scientist Requirements cited from several current job postings: –“PharmD + minimum of 1 year (to 5 yrs) of related experience” –“Fellowship in Clinical Pharmacology is desired” –“Experience in academic and industry early phase clinical trial design conduct” –“Knowledge of [bone metabolism] desirable”

Ideal Candidate for Clinical Scientist Position (in Oncology) Formal training in a clinical discipline; knowledge of clinical labs, disease states, pharmacology, pharmacokinetics, … Specific knowledge of oncology disease states, treatments, complications, … Knowledge of clinical trial methodologies, statistics, endpoints, … Experience in industry-sponsored R&D.

Clinical Research Associate Responsible for ensuring the validity, accuracy, and completeness of clinical research records by monitoring clinical trial data. Responsible for ensuring that study conduct complies with required Regulatory procedures. Common entry point for PharmDs with limited industry experience.

Medical Writer Responsible for creating internal documents that summarize the results of clinical trials. Works with research projects from early studies through final FDA document preparation. A possible, but not common, entry point for PharmDs with limited industry experience.

Outcomes Research Scientist Responsible for developing protocols, implementing, conducting, interpreting, and summarizing clinical studies that focus on quality of life endpoints, clinical utility measures, pharmacoeconomic assessments, etc. Generally would require some specialized training (as per a Fellowship?)

Regulatory Affairs Department Responsible for managing the interface between the Sponsor and Regulatory Agencies (eg, FDA) so that the information gained through the R&D process meets the criteria for product registration. A possible, but not common, entry point for PharmDs with limited industry experience.

Additional Departments with Possible Career Opportunities for PharmDs No further degree or formal training program is required: –Clinical Quality Assurance Department –Safety Surveillance Department Possible, but not common, entry points for PharmDs with limited industry experience.

Additional Departments with Possible Career Opportunities for PharmDs Formal degree, training, or experience is usually required/preferred: –Pharmacokinetics & Drug Metabolism Department –Licensing & Acquisitions Department –Literature Services Department –Project Management –Market Planning Department

‘So, how can I get a cushy R&D Job without having R&D Experience?”

1.Be prepared to start with a job other than your ‘ideal’ job. Gain industry-based R&D experience, establish your reputation, look for internal or external opportunities.

‘So, how can I get a cushy R&D Job without having R&D Experience?” 2.Initially seek employment with: a Contract Research Organization (CRO) that supports pharmaceutical-based R&D, or an academic center that has a strong clinical research component.

‘So, how can I get a cushy R&D Job without having R&D Experience?” 3.Build your knowledge and experience level to match the desired attributes. Seminars or courses in clinical trial design, statistics, business, etc. Specialized disease knowledge Publish (something -- anything!) Research fellowship

Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development